Previous close | 61.05 |
Open | 61.51 |
Bid | 61.23 x 900 |
Ask | 61.95 x 800 |
Day's range | 60.79 - 62.12 |
52-week range | 57.49 - 89.70 |
Volume | |
Avg. volume | 2,978,633 |
Market cap | 30.846B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 30.78 |
EPS (TTM) | 1.99 |
Earnings date | 26 Oct 2022 - 31 Oct 2022 |
Forward dividend & yield | 1.16 (1.89%) |
Ex-dividend date | 01 Sept 2022 |
1y target est | 72.85 |
Shares of Baxter International (NYSE: BAX) were tumbling 8.8% lower as of 11:24 a.m. ET on Thursday after falling as much as 11.8% earlier in the day. The decline came after the healthcare company announced its second-quarter financial results. The company posted Q2 adjusted earnings per share of $0.87, in line with the average estimate of analysts surveyed by Refinitiv.
Baxter's (BAX) second-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.
Baxter (BAX) delivered earnings and revenue surprises of -1.14% and 3.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?